Related Experiment Video
Updated: Aug 2, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation
1Department of Pathology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan.
Abstract:
Signals emanated from CD30 can activate the nuclear factor kappaB (NFkappaB). The two conserved subdomains, D1 and D2, in the C-terminal cytoplasmic region of CD30 were tested for interaction with two tumor necrosis factor receptor-associated factor (TRAF) proteins with NFkappaB activating capacity, TRAF2 and TRAF5. TRAF5 is the newest member of the TRAF family that binds to lymphotoxin beta receptor and CD40. TRAF5, as well as TRAF2, interacted with the D2 subdomain of CD30 in vitro and in vivo. Deletion analysis by the yeast two-hybrid system revealed that the C-terminal 22 and 30 amino acid residues are dispensable for interaction of TRAF5 and TRAF2 with CD30, respectively. Substitution of alanine for threonine at 463 abolished the interaction with TRAF2. Overexpression of the TRAF domain of TRAF2 or TRAF5 showed a dominant negative effect on CD30-mediated NFkappaB activation. Simultaneous expression of these TRAF domains further suppressed the NFkappaB activation, suggesting an interplay of these TRAF proteins. Expression of TRAF2 and TRAF5 mRNA was demonstrated in T- and B-cell lines that express CD30. Taken together, our results indicate that TRAF2 and TRAF5 directly interact with CD30 and are involved in NFkappaB activation by CD30 signaling.
Insights
CD30 signaling activates nuclear factor kappaB (NFkappaB) through interactions with TRAF2 and TRAF5. These tumor necrosis factor receptor-associated factor proteins bind to CD30
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- CD30 is a receptor involved in immune responses.
- Nuclear factor kappaB (NFkappaB) is a key transcription factor in immunity.
Purpose of the Study:
- To investigate the interaction between CD30 and tumor necrosis factor receptor-associated factor (TRAF) proteins.
- To elucidate the role of TRAF2 and TRAF5 in CD30-mediated NFkappaB activation.
Main Methods:
- Yeast two-hybrid system for interaction analysis.
- In vitro and in vivo binding assays.
- Dominant-negative assays using TRAF domains.
Main Results:
- TRAF2 and TRAF5 directly interact with the D2 subdomain of CD30.
- Specific amino acid residues in CD30 are critical for TRAF binding.
- Overexpression of TRAF domains inhibits CD30-induced NFkappaB activation.
- TRAF2 and TRAF5 mRNA are expressed in CD30-expressing immune cells.
Conclusions:
- TRAF2 and TRAF5 are key mediators of CD30 signaling.
- These TRAF proteins directly bind CD30 and activate NFkappaB.
- The findings reveal a novel mechanism in immune cell activation pathways.
More Related Videos
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
TGF - β Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

